Ally Bridge Group (Ny) LLC Tarsus Pharmaceuticals, Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $76.1 Million
- Q1 2025
A detailed history of Ally Bridge Group (Ny) LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 127,932 shares of TARS stock, worth $6.12 Million. This represents 8.64% of its overall portfolio holdings.
Number of Shares
127,932
Previous 173,144
26.11%
Holding current value
$6.12 Million
Previous $9.59 Million
31.45%
% of portfolio
8.64%
Previous 10.88%
Shares
3 transactions
Others Institutions Holding TARS
# of Institutions
208Shares Held
44.3MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$159 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$156 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$125 Million6.87% of portfolio
-
Jennison Associates LLC2.47MShares$118 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$117 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.28B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...